[(2S,3R,5S,8R,9S,10S,13R,14S,17R)-3-(2-hydroxyphenyl)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-2-yl] methanesulfonate

C34H54O4S — CID 10721578

IUPAC[(2S,3R,5S,8R,9S,10S,13R,14S,17R)-3-(2-hydroxyphenyl)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-2-yl] methanesulfonate
SMILESCC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](c5ccccc5O)[C@@H](OS(C)(=O)=O)C[C@]4(C)[C@H]3CC[C@]12C
InChIInChI=1S/C34H54O4S/c1-22(2)10-9-11-23(3)28-16-17-29-26-15-14-24-20-27(25-12-7-8-13-31(25)35)32(38-39(6,36)37)21-34(24,5)30(26)18-19-33(28,29)4/h7-8,12-13,22-24,26-30,32,35H,9-11,14-21H2,1-6H3/t23-,24+,26+,27-,28-,29+,30+,32+,33-,34+/m1/s1
InChIKeyKYGNAEHBUBJVLN-KVAAYNCZSA-N
MW558.87 g/mol
LogP8.55
Rot. Bonds8

About [(2S,3R,5S,8R,9S,10S,13R,14S,17R)-3-(2-hydroxyphenyl)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-2-yl] methanesulfonate

[(2S,3R,5S,8R,9S,10S,13R,14S,17R)-3-(2-hydroxyphenyl)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-2-yl] methanesulfonate (PubChem CID 10721578) has the molecular formula C34H54O4S and a molecular weight of 558.87 g/mol. Its IUPAC name is [(2S,3R,5S,8R,9S,10S,13R,14S,17R)-3-(2-hydroxyphenyl)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-2-yl] methanesulfonate.

Molecular Properties

Compound Name[(2S,3R,5S,8R,9S,10S,13R,14S,17R)-3-(2-hydroxyphenyl)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-2-yl] methanesulfonate
PubChem CID10721578
Molecular FormulaC34H54O4S
Molecular Weight558.87 g/mol
Exact Mass558.37
IUPAC Name[(2S,3R,5S,8R,9S,10S,13R,14S,17R)-3-(2-hydroxyphenyl)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-2-yl] methanesulfonate
SMILESCC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](c5ccccc5O)[C@@H](OS(C)(=O)=O)C[C@]4(C)[C@H]3CC[C@]12C
InChIInChI=1S/C34H54O4S/c1-22(2)10-9-11-23(3)28-16-17-29-26-15-14-24-20-27(25-12-7-8-13-31(25)35)32(38-39(6,36)37)21-34(24,5)30(26)18-19-33(28,29)4/h7-8,12-13,22-24,26-30,32,35H,9-11,14-21H2,1-6H3/t23-,24+,26+,27-,28-,29+,30+,32+,33-,34+/m1/s1
InChIKeyKYGNAEHBUBJVLN-KVAAYNCZSA-N
XLogP8.55
TPSA63.60 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds8
Heavy Atoms39
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500558.87
LogP ≤ 58.55
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Sulfonic_acid_1', 'substructure': 'N/A'}

Analyze [(2S,3R,5S,8R,9S,10S,13R,14S,17R)-3-(2-hydroxyphenyl)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-2-yl] methanesulfonate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

[(2S,3S,10S,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2-sulfooxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate
CID 10415490
[(2S,3S,5S,10S,13R,17R)-3-hydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-2-yl] hydrogen sulfate
CID 513880
[(3S,5R,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-[(2S)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] methanesulfonate
CID 99571551
(2R,3S,5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-3-phenoxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-2-ol
CID 23253081
(8R,9S,10S,13R,14S,17R)-2-methoxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol
CID 57362938
[(2R,3S,5S,8R,9R,10S,13S,14R,17R)-2-acetyloxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
CID 125035313
[(3R,5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate
CID 99594443
[(2S,3R,5S,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-2-yl] 2-iodoacetate
CID 101422091
azane;[(3S,5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate
CID 175821433
(1S,2S,4R,7S,9R,12R,13S,16R,17R)-5,5-dichloro-2,17-dimethyl-16-[(2R)-6-methylheptan-2-yl]pentacyclo[10.7.0.02,9.04,7.013,17]nonadecan-6-one
CID 134919891
[(2R,3S,5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-3-phenyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-2-yl] 2-[(2S)-oxan-2-yl]acetate
CID 11039219
(2S,5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-2-ol
CID 12724561

Frequently Asked Questions

What is the IUPAC name of [(2S,3R,5S,8R,9S,10S,13R,14S,17R)-3-(2-hydroxyphenyl)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-2-yl] methanesulfonate?
The IUPAC name of [(2S,3R,5S,8R,9S,10S,13R,14S,17R)-3-(2-hydroxyphenyl)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-2-yl] methanesulfonate (CID 10721578) is [(2S,3R,5S,8R,9S,10S,13R,14S,17R)-3-(2-hydroxyphenyl)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-2-yl] methanesulfonate.
What is the SMILES notation for [(2S,3R,5S,8R,9S,10S,13R,14S,17R)-3-(2-hydroxyphenyl)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-2-yl] methanesulfonate?
The canonical SMILES for [(2S,3R,5S,8R,9S,10S,13R,14S,17R)-3-(2-hydroxyphenyl)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-2-yl] methanesulfonate is CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](c5ccccc5O)[C@@H](OS(C)(=O)=O)C[C@]4(C)[C@H]3CC[C@]12C.
What is the InChIKey of [(2S,3R,5S,8R,9S,10S,13R,14S,17R)-3-(2-hydroxyphenyl)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-2-yl] methanesulfonate?
The InChIKey is KYGNAEHBUBJVLN-KVAAYNCZSA-N. The full InChI is InChI=1S/C34H54O4S/c1-22(2)10-9-11-23(3)28-16-17-29-26-15-14-24-20-27(25-12-7-8-13-31(25)35)32(38-39(6,36)37)21-34(24,5)30(26)18-19-33(28,29)4/h7-8,12-13,22-24,26-30,32,35H,9-11,14-21H2,1-6H3/t23-,24+,26+,27-,28-,29+,30+,32+,33-,34+/m1/s1.
What are the key properties of [(2S,3R,5S,8R,9S,10S,13R,14S,17R)-3-(2-hydroxyphenyl)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-2-yl] methanesulfonate?
[(2S,3R,5S,8R,9S,10S,13R,14S,17R)-3-(2-hydroxyphenyl)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-2-yl] methanesulfonate has a molecular weight of 558.87 g/mol, XLogP of 8.55, 8 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for [(2S,3R,5S,8R,9S,10S,13R,14S,17R)-3-(2-hydroxyphenyl)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-2-yl] methanesulfonate is sourced from PubChem (CID 10721578), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).